Siemens Healthcare has received U.S. Food and Drug Administration (FDA) 510(k) clearance for syngo Neuro PBV, an application for qualitative assessment of cerebral blood flow during interventional procedures.
Syngo Neuro PBV IR (parenchymal blood volume, interventional radiology) provides visual assistance to physicians for diagnosing and treating vessel malformations such as aneurysms, arteriovenous malformations, and stenoses, according to the vendor. In neuroradiology, this feature assists physicians in treating stroke patients by displaying a color-coded qualitative map of cerebral tissue directly in the angiography suite, according to Siemens.
Syngo Neuro PBV IR is available with the company's Artis zee line of interventional x-ray systems for radiology and cardiology.
